Company: IPHYF
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001598599-25-000042
Chunk: 367

Company: Innate Pharma SA
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 367
---
 of the Executive Board, Supervisory Board and Leadership Team               846,944        1.01%                      911,444        1.08%  
  Treasury shares                                                                      18,575        0.02%                            0           —%  
  Public                                                                           59,286,440       70.71%                   59,995,085       70.92%  
  Total                                                                            83,844,411      100.00%                   84,598,981      100.00%  

After closing

  Shareholder                                                                Nb of Shares [1] *            %      Nb of voting rights [2]            %  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Novo Nordisk A/S                                                                    9,817,546       10.65%                    9,817,546       10.56%  
  Sanofi-Aventis Participations                                                       8,345,387        9.05%                    8,345,387        8.98%  
  Medimmune Limited                                                                   7,485,500        8.12%                    7,485,500        8.05%  
  Bpifrance Participations                                                            6,389,406        6.93%                    6,389,406        6.87%  
  Members of the Executive Board, Supervisory Board and Leadership Team                 846,944        0.92%                      911,444        0.98%  
  Treasury shares                                                                        18,575        0.02%                            0           —%  
  Public                                                                             59,286,440       64.31%                   59,995,085       64.55%  
  Total                                                                              92,189,798      100.00%                   92,944,368      100.00%  

[1] Ordinary shares includes ordinary shares plus ordinary shares pursuant to the 2016 and 2017 free preference shares.

F-88

F-89

117 avenue de Luminy 13009 Marseille - France

www. innate-pharma. com